The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The goal of the DSUVIA REMS is to mitigate the risk of respiratory depression resulting from
accidental exposure by
ensuring that DSUVIA is dispensed only to patients in certified medically supervised healthcare settings.
What do participants need to know?
Below is a general overview of the REMS for all REMS participants (e.g., patients, pharmacies, and healthcare providers). See the application holder(s) REMS Website or the approved REMS materials for more information.
Be able to manage acute opioid overdose, including respiratory
depression.
Designate an authorized representative to carry out the certification
process and oversee implementation and compliance with the REMS
Program on behalf of the healthcare setting.
Have the authorized representative enroll in the REMS Program by
completing the Healthcare Setting Enrollment Form and submitting it
to the REMS Program.
| Healthcare Setting Enrollment Form |
Train all relevant staff that DSUVIA must not be dispensed for use
outside of the certified healthcare setting.
Train all relevant staff involved in administration of DSUVIA to refer to
the Directions for Use prior to administration.
Establish processes and procedures to verify that DSUVIA is not
dispensed for use outside of the certified healthcare setting.
To maintain
certification to
dispense
Have a new authorized representative enroll in the REMS Program by
completing the Healthcare Setting Enrollment Form if the authorized
representative changes.
| Healthcare Setting Enrollment Form |
At all times
Not dispense DSUVIA for use outside the certified healthcare setting.
Not distribute, transfer, loan or sell DSUVIA.
Maintain records of staff training.
Maintain records of all processes and procedures including compliance
with those processes and procedures.
Comply with audits by Vertical Pharmaceuticals, LLC or a third party
acting on behalf of Vertical Pharmaceuticals, LLC to ensure that all
processes and procedures are in place and are being followed.
Wholesalers-distributors that distribute DSUVIA must:
To be able to
distribute
Establish processes and procedures to ensure that DSUVIA is
distributed only to certified healthcare settings.
Train all relevant staff involved in distributing DSUVIA on the
processes and procedures to verify the healthcare settings are
certified.
At all times
Distribute only to certified healthcare settings.
Maintain and submit records of all shipments of DSUVIA to Vertical
Pharmaceuticals, LLC.
Comply with audits carried out by Vertical Pharmaceuticals, LLC or a
third party acting on behalf of Vertical Pharmaceuticals, LLC to ensure
that all processes and procedures are in place and are being followed.
What materials are included in the REMS?
The REMS includes a REMS Document. In addition, the REMS includes the following materials intended for patients and healthcare providers.
This webpage provides REMS assessment plan measures, metrics, and indicators for drug and biological products with a REMS. The REMS assessment plan measures, metrics, and indicators are part of the overall REMS assessment plan used by FDA to evaluate the performance of a REMS and are included in FDA approval letters. The current REMS assessment plan measures, metrics, and indicators are extracted from regulatory letters that contain REMS information, including FDA approval letters, and posted here as they become available.
What updates have been made to the REMS?
Date
Summary of change
12/19/2023
Changes in the application holder name to reflect transfer of application ownership
04/21/2022
Modified to make changes to the auditing of
healthcare settings to annually audit all certified healthcare settings (or a maximum of
400), that have received at least one shipment of Dsuvia in the past 6 months.
11/02/2018
Approval of REMS.
Disclaimer: This webpage provides general information about REMS programs
to various REMS participants (e.g., patients, pharmacies, and healthcare providers).
The summary information provided herein is not comprehensive and may not include
all of the information relevant to REMS participants. This webpage does not
constitute a replacement, modification, or revision of the approved REMS document,
including any appended REMS materials. Refer to the approved REMS document
for complete information on the REMS requirements for each approved application.
